Compositions of azimilide dihydrochloride

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9035052
APP PUB NO 20130217701A1
SERIAL NO

13840612

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to solvates and various polymorphic forms of (E)-1-[[[5-(4-chlorophenyl)-2-furanyl]methylene]amino]-3-[4-(4-methyl-1-piperazinyl)butyl]-2,4-imidazolidinedione dihydrochloride and pharmaceutical compositions thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITEDCLONSHAUGH BUSINESS & TECHNOLOGY PARK DUBLIN 17 D17 E40 IRELAND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baker, Tammy South Lebanon, US 7 9
Geary, Nicholas William Cincinnati, US 46 523
Redman-Furey, Nancy Lee Morrow, US 11 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 19, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00